| Number of cases | TAGLN immunostaining | P | |
---|---|---|---|---|
Weak(+) | Strong(++) | |||
Gender | Â | Â | Â | 0.778 |
  Male | 60 | 27 | 33 |  |
  Female | 38 | 16 | 22 |  |
Age | Â | Â | Â | 0.739 |
  ≤60y | 46 | 21 | 25 |  |
  >60y | 52 | 22 | 30 |  |
Tumor size | Â | Â | Â | 0.852 |
  ≤5 cm | 58 | 25 | 33 |  |
  >5 cm | 40 | 18 | 22 |  |
Differentiation | Â | Â | Â | 0.003 |
  Well + Moderate | 46 | 13 | 33 |  |
  Poor | 52 | 30 | 22 |  |
Lauren classification | Â | Â | Â | 0.059 |
  Intestinal | 40 | 13 | 27 |  |
  Diffuse | 58 | 30 | 28 |  |
T stage | Â | Â | Â | 0.142 |
  T1 + T2 | 56 | 21 | 35 |  |
  T3 + T4 | 42 | 22 | 20 |  |
Lymph node metastasis | Â | Â | Â | 0.029 |
  N0 | 27 | 11 | 16 |  |
  N1 | 32 | 15 | 17 |  |
  N2 | 26 | 7 | 19 |  |
  N3 | 13 | 10 | 3 |  |
Distant metastasis | Â | Â | Â | 0.709 |
  Without | 95 | 42 | 53 |  |
  With | 3 | 1 | 2 |  |
TNM stage | Â | Â | Â | 0.722 |
  I | 20 | 7 | 13 |  |
  II | 25 | 11 | 14 |  |
  III | 30 | 10 | 20 |  |
  IV | 23 | 15 | 8 |  |